Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Bispecific BCMA/CD24 C
Disparities in Kaposi
Standard and novel ima
Experiencing Sexual As
Novel orally active ep
See All (10) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity.
Khan MA, Liu J, Kumar G, Skapek SX, Falck JR, Imig JD. Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. FASEB J. 2013 Aug; 27(8):2946-56.
View in:
PubMed
subject areas
8,11,14-Eicosatrienoic Acid
Administration, Oral
Animals
Apoptosis
Blood Urea Nitrogen
Cell Line, Tumor
Cell Survival
Cisplatin
Creatinine
Cross-Linking Reagents
Dose-Response Relationship, Drug
Endoplasmic Reticulum Stress
Gene Expression
HEK293 Cells
HeLa Cells
Humans
Kidney
Kidney Diseases
Male
Proto-Oncogene Proteins c-bcl-2
Rats
Rats, Inbred WKY
Reverse Transcriptase Polymerase Chain Reaction
Superoxide Dismutase
Vasodilator Agents
authors with profiles
John Imig